Skip to main content
Figure 2 | BMC Dermatology

Figure 2

From: Eruptive papules during efalizumab (anti-CD11a) therapy of psoriasis vulgaris: a case series

Figure 2

Immunohistochemistry of papular lesions from three representative patients. (A) Patient 5, (B) Patient 8, (C) Patient 10. Staining with H&E, keratin 16 (K16), CD3+ T cells, α chain of β2 integrins CD11a (blocked by efalizumab), CD11b, CD11c, iNOS, and neutrophil elastase. There are abundant CD11b, CD11c+, and iNOS+ cells in the lesions, with relatively less CD3+ lymphocytes.

Back to article page